We believe in changing the paradigm of preclinical study to
⚕️ Accelerate the development of personalized medicine
💊 Better predict a drug effect on a human body
🐁 Accelerate the development of an alternative to animal models
The way we are changing it is by using the power of industrialized microfluidic to mimick a physio-pathology of a human body in vitro
We design Microphysiological Systems compatible with a multiwell standard
Main Features
The only commercial MPS PDMS free device with no bias in toxicology and efficacy studies
Direct integration in existing analysis workflow, without disruption of the culture conditions
From 6 to 24 well allowing a direct transfer of the culture protocol
Physiological maintenance of a differentiated endothelium with an organ stroma >5 days
Our Experience
Our mission is to develop the most advanced technological platform for predicting the impact of molecules (drug, endocrine disruptor, cosmetic, etc.) on the human body to better treat pathologies (orphan diseases, cancer, bacterial resistance, virus). Moreover, This platform is an alternative to use less animals model by combining new microfluidic technology , artificial intelligence and most advanced imaging techniques.
Testimonials
Learn how Cubix impacted researchers, the first incubator-free microenvironment controller in the world. Enabled the mimicking of physiological and pathological culture conditions in vitro. CubiX is the only microenvironment controller fully compatible with live imaging. You will never be blind to your sample ever.
CubiX is scalable & customizable allowing you to use custom made chips, multiwell, commercial microfluidic chip, and many more to help you get better and longer biological culture.
Cubix for Pharmaceautical and Biotech Companies
- Benefits: Lower false positive drug candidate in preclinical phases, accelerate the drug development process, leading to drastic cost reduction
- How?: Obtain a functional 3D vascularized adipose tissue in medium-throughput, for a hit to lead and lead characterization
Cubix for Academic and Translational Researchers
- Benefits: New fundamental discovery leading to higher publications impact and increase Shanghai ranking
- How?: Obtain a functional 3D vascularized adipose tissue long term (> 2weeks) for new molecular target identification and mechanism of action deciphering
Diabetes Knowlegde Centre
